Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

409

Participants

Timeline

Start Date

July 13, 2021

Primary Completion Date

March 7, 2025

Study Completion Date

August 28, 2025

Conditions
Post Surgical Neuropathic Pain
Interventions
DRUG

Qutenza (capsaicin) 8% topical system

High concentration capsaicin

DRUG

capsaicin 0.04% topical system

Low-dose capsaicin control

Trial Locations (64)

10022

Ainsworth Institute of Pain Management, New York

19406

Main Line Spine, King of Prussia

20006

International Spine, Pain, and Performance Center, Washington D.C.

27103

The Center for Clinical Research, Winston-Salem

28401

Accellacare, Wilmington

30060

Drug Studies America, Marietta

32720

University Clinical Research - DeLand Clinical Research Unit, DeLand

33174

Florida Research Center, Inc., Miami

33606

Clinical Research of West Florida, Tampa

34711

South Lake Pain Institute, Clermont

37909

New Phase Research & Development, Knoxville

45432

META Medical Research Institute, LLC, Dayton

48706

Great Lakes Research Group, Inc., Bay City

60612

Rush University Medical Center, Chicago

66210

Neuroscience Research Center, LLC, Overland Park

66211

Kansas City Bone & Joint Clinic, P.A., Overland Park

77079

Expert Pain, Houston

78229

The University of Texas Health Science Center at San Antonio, San Antonio

84107

Wasatch Clinical Research, LLC, Salt Lake City

85712

Tucson Orthopaedic Institute, Tucson

92009

ILD Research Center, Vista

02131

Boston Clinical Trials, Boston

07702

Premier Pain Centers, Shrewsbury

Unknown

Centre Hospitalier Departemental Vendee - Centre d'evaluation et de Traitement de la Douleur, La Roche-sur-Yon

CHU de Nantes - Hopital Nord Laennec, Nantes

CHU Amiens Picardie, Amiens

Centre Regional De Lutte Contre Le Cancer (Crlcc) -Centre Paul Papin, Angers

Centre Hospitalier Jean Rougier, Cahors

Centre Hospitalier Universitaire de Clermont Ferrand, Clermont-Ferrand

Centre Hospitalier Regional Universitaire (CHRU) de Lille - Hopital Claude Huriez, Lille

Clinique Francois Chenieux, Limoges

Cochin Hospital-Paris Descartes University, Paris

Groupe Hospitalier Paris saint-Joseph, Paris

CHU Poitiers / La Miletrie, Poitiers

VUMC, Amsterdam

PT&R, Beek

NOCEPTA, Hengelo

Leiden University Medical Center (LUMC), Leiden

Centrum Medyczne Pratia Katowice, Katowice

Silmedic Sp z o.o. Oddzial w Katowicach, Katowice

Vitamed Nzoz Im. Edyty Jakubow, Bialystok

Nzoz Neuro-Medic, Katowice

Linden Centrum Medyczne, Krakow

Instytut Zdrowia dr Boczarska-Jedynak, Oświęcim

Lubelskie Centrum Diagnostyczne, Świdnik

Centrum Badan Medycznych Nigrir, Warsaw

FutureMeds sp. z o. o., Wroclaw

Hospital General Universitario de Alicante, Alicante

Hospital Universitario de La Princesa, Madrid

Hospital Clinico Universitario de Valencia, Valencia

Hospital Del Mar, Barcelona

Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat

Hospital Universitario La Moraleja, Madrid

Hospital Quironsalud Malaga, Málaga

Clinica Universidad de Navarra, Pamplona

Clinica Gaias, Santiago de Compostela

Hospital Clinico Universitario de Valladolid, Valladolid

Accellacare - (MeDiNova Limited) - Northamptonshire, Corby

Accellacare - (MeDiNova Limited) - Yorkshire, Shipley

Aberdeen Royal Infirmary (ARI) - NHS Grampian, Aberdeen

Accellacare, Coventry

Leeds General Infirmary - Leeds Teaching Hospitals NHS Trust, Leeds

Accellacare - (MeDiNova Limited) - North London, Northwood

MeDiNova South London Quality Research Site, Sidcup

Sponsors
All Listed Sponsors
lead

Averitas Pharma, Inc.

INDUSTRY